We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$43.1B
AUM Growth
+$1.45B
Cap. Flow
-$96.7M
Cap. Flow %
-0.22%
Top 10 Hldgs %
45.82%
Holding
319
New
11
Increased
71
Reduced
116
Closed
14

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$194M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
UNH icon
UnitedHealth
UNH
+$137M
4
META icon
Meta Platforms (Facebook)
META
+$117M
5
PM icon
Philip Morris
PM
+$68.8M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$184M
2
HES
Hess
HES
+$175M
3
NKE icon
Nike
NKE
+$95.7M
4
PEP icon
PepsiCo
PEP
+$94.4M
5
AAPL icon
Apple
AAPL
+$83.3M

Sector Composition

Rank Sector Weight
1 Technology 31.75%
2 Financials 18.34%
3 Consumer Staples 10.86%
4 Healthcare 8.86%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$134B
$528M 1.23%
1,169,350
+60,210
+5% +$28.9M
TROW icon
27
T. Rowe Price
TROW
$22.6B
$518M 1.2%
5,045,436
-203,550
-4% -$21.4M
ABBV icon
28
AbbVie
ABBV
$463B
$501M 1.16%
2,163,305
-4,690
-0.2% -$955K
ETN icon
29
Eaton
ETN
$153B
$474M 1.1%
1,256,177
+40,792
+3% +$14.8M
NVO
30
Novo Nordisk
NVO
$192B
$408M 0.95%
7,353,587
-3,150,075
-30% -$184M
ADP icon
31
Automatic Data Processing
ADP
$110B
$397M 0.92%
1,352,576
+15,383
+1% +$4.63M
CP icon
32
Canadian Pacific Kansas City
CP
$78.9B
$364M 0.84%
4,822,202
+92,424
+2% +$7.06M
MO icon
33
Altria Group
MO
$118B
$352M 0.82%
5,335,186
-98,830
-2% -$6.26M
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.1T
$351M 0.81%
697,587
-3,406
-0.5% -$1.65M
NOW icon
35
ServiceNow
NOW
$147B
$342M 0.79%
1,836,235
+139,880
+8% +$26.1M
ICE icon
36
Intercontinental Exchange
ICE
$88.6B
$340M 0.79%
2,015,426
-11,289
-0.6% -$2.02M
CME icon
37
CME Group
CME
$101B
$338M 0.78%
1,249,296
+7,866
+0.6% +$2.14M
UNP icon
38
Union Pacific
UNP
$169B
$334M 0.77%
1,412,177
-274,038
-16% -$61.8M
LLY icon
39
Eli Lilly
LLY
$1.01T
$333M 0.77%
436,162
+10,522
+2% +$7.83M
CB icon
40
Chubb
CB
$132B
$329M 0.76%
1,163,938
-10,984
-0.9% -$3.02M
AZN icon
41
AstraZeneca
AZN
$254B
$299M 0.69%
1,947,219
+74,268
+4% +$11.2M
BRK.A icon
42
Berkshire Hathaway Class A
BRK.A
$1.1T
$292M 0.68%
387
-5
-1% -$3.63M
HD icon
43
Home Depot
HD
$310B
$287M 0.67%
708,067
+23,796
+3% +$9.36M
MS icon
44
Morgan Stanley
MS
$324B
$287M 0.67%
1,803,873
-40,184
-2% -$5.93M
MAR icon
45
Marriott International
MAR
$88.8B
$256M 0.59%
971,981
+4,534
+0.5% +$1.22M
SHW icon
46
Sherwin-Williams
SHW
$78.8B
$232M 0.54%
670,046
+4,000
+0.6% +$1.41M
BNY
47
Bank of New York Mellon
BNY
$107B
$232M 0.54%
2,128,778
-50,712
-2% -$5.17M
MDLZ icon
48
Mondelez International
MDLZ
$79.6B
$224M 0.52%
3,585,045
-173,874
-5% -$11.2M
PEP icon
49
PepsiCo
PEP
$186B
$221M 0.51%
1,576,443
-661,393
-30% -$94.4M
BX icon
50
Blackstone
BX
$96.3B
$217M 0.5%
1,270,608
+24,237
+2% +$4.15M

Similar funds

Fayez Sarofim & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Fayez Sarofim & Co held 319 positions worth $43.1B, up 3.5% from $41.7B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fayez Sarofim & Co's Q3 2025 filing shows 11 new, 71 increased, 116 reduced and 14 closed positions. Its largest new stake was SAP: 49,674 shares worth $13.3M. The largest sale was Novo Nordisk, an estimated $184M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q3 2025 buy was SAP: 49,674 shares worth $13.3M.
  • Fayez Sarofim & Co added most to Chevron in Q3 2025, an estimated $194M increase.
  • Fayez Sarofim & Co's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $184M.
  • Fayez Sarofim & Co fully exited Hess in Q3 2025, selling an estimated $175M.
  • Fayez Sarofim & Co's ten largest holdings make up 46% of its $43.1B portfolio in Q3 2025.
  • Fayez Sarofim & Co opened 11 new positions and closed 14 in Q3 2025.
  • Fayez Sarofim & Co's portfolio value rose 3.5% quarter-over-quarter to $43.1B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2025, filed 14 Nov 2025.